Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Telitacicept for IgA Nephropathy - Interim Analysis of a Phase 3 Trial

New England Journal of Medicine - 13 May 2026 09:00
New England Journal of Medicine, Volume 394, Issue 19, Page 1916-1924, May 1421, 2026.
Full Article at New England Journal of Medicine

More Medical News
0
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard